# Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.

> **NCT05853185** · PHASE4 · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 64 (actual)

## Conditions studied

- Pulpitis - Irreversible

## Interventions

- **DRUG:** Pro Root MTA®
- **DRUG:** EBRRM®

## Key facts

- **NCT ID:** NCT05853185
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-12
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05853185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05853185, "Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05853185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*